Diversity in Life Sciences

Initiatives to Enhance Diversity, Equity & Inclusion in Science


View All Fellows

David A. Alagpulinsa, PhD
Massachusetts General Hospital and Harvard Medical School

Dr. David Alagpulinsa received a bachelor’s degree in Pharmacy from Kwame Nkrumah University of Science & Technology, Kumasi, Ghana, and a PhD in Interdisciplinary Biomedical Sciences from the University of Arkansas for Medical Sciences. He completed his postdoctoral training at the Massachusetts General Hospital (MGH) and Harvard Medical School in Boston, where he is currently a faculty Instructor in Medicine and Investigation. His research interests include genomic instability, hematopoiesis, autoimmunity, and cardiovascular disease. 


Dr. Alagpulinsa was the MGH nominee for the American Diabetes Association Pathway to Stop Diabetes Initiator Award and was recently awarded the JDRF Diversifying Diabetes Research Talent in Academia Grant Award. His current research focuses on the role of bone marrow hematopoiesis in type 1 diabetes and cardiovascular disease. Dr. Alagpulinsa is a past recipient of the Keystone Symposia Global Health Travel Award.  

Research Area(s):

Metabolic Disease

Research Keywords:

# Cardiovascular Disease
# Inflammation
# Autoimmune diseases
# Hematopoiesis
# DNA Damage

Mentor: Arturo Zychlinsky, PhD

Back to Fellows List


From the KeyPoint Blog

16 min read

Keypoint Newsletter:  Welcome to the Fellows Class of 2023

By Heather Gerhart

Keystone Symposia is pleased to introduce the Keystone Symposia Fellows Class of 2023! This year we...

12 min read

Partnering with Eli Lilly to Empower Diversity in the Biomedical Workforce

Keystone Symposia was founded on the idea of bringing academic and industry scientists together to accelerate...

Subscribe for Updates